The Centre for Research on Eating Disorders at Oxford (CREDO) has been in existence since 1981. It has been responsible for the development and evaluation of many of the leading treatments for adults with eating disorders. These are in use worldwide. They include:
CREDO also developed some of the most widely used measures of eating disorder features and impact:
Currently, the main focus of CREDO’s research is on the development and evaluation of a direct-to-user form of CBT-E delivered via the internet. It is called “Digital CBTe.”
If you want to learn more about CREDO visit www.credo-oxford.com.
CREDO has been funded by the Wellcome Trust since 1984 (www.wellcome.ac.uk). The Wellcome Trust is an independent global charitable foundation. It is independent from governments, from industry and from donors. It invests more than £700 million a year in science, the humanities and the social sciences, as well as education, public engagement and the application of research to medicine.